ATE216254T1 - Pharmazeutische zusammensetzungen enthaltend cyclosporin und einen träger mit mindestens einer ester-alpha-glycerophosphorsäure - Google Patents

Pharmazeutische zusammensetzungen enthaltend cyclosporin und einen träger mit mindestens einer ester-alpha-glycerophosphorsäure

Info

Publication number: ATE216254T1
Authority: AT; Austria
Prior art keywords: alpha; carrier; pharmaceutical compositions; compositions containing; ester
Prior art date: 1996-05-20

Application number

AT97924958T

Other languages

English (en)

Inventor

Alberto Salini

Original Assignee

Flarer S A

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-05-20

Filing date

1997-05-20

Publication date

2002-05-15

1997-05-20 Application filed by Flarer S A filed Critical Flarer S A

2002-05-15 Application granted granted Critical

2002-05-15 Publication of ATE216254T1 publication Critical patent/ATE216254T1/de

Links

PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 title abstract 3
108010036949 Cyclosporine Proteins 0.000 title abstract 3
229960001265 ciclosporin Drugs 0.000 title abstract 3
229930182912 cyclosporin Natural products 0.000 title abstract 3
239000008194 pharmaceutical composition Substances 0.000 title abstract 2
229960004788 choline alfoscerate Drugs 0.000 abstract 1
AWUCVROLDVIAJX-UHFFFAOYSA-N glycerol 1-phosphate Chemical class OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 abstract 1
JZNWSCPGTDBMEW-UHFFFAOYSA-N glycerophosphatidylethanolamine Chemical compound NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 abstract 1
SUHOQUVVVLNYQR-MRVPVSSYSA-O glycerylphosphorylcholine Chemical compound C[N+](C)(C)CCO[P@](O)(=O)OC[C@H](O)CO SUHOQUVVVLNYQR-MRVPVSSYSA-O 0.000 abstract 1
229960000367 inositol Drugs 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Tropical Medicine & Parasitology (AREA)
Physical Education & Sports Medicine (AREA)
Rheumatology (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Epidemiology (AREA)
Dermatology (AREA)
Ophthalmology & Optometry (AREA)
Pain & Pain Management (AREA)
Orthopedic Medicine & Surgery (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AT97924958T 1996-05-20 1997-05-20 Pharmazeutische zusammensetzungen enthaltend cyclosporin und einen träger mit mindestens einer ester-alpha-glycerophosphorsäure ATE216254T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IT96MI001010A IT1282733B1 (it)	1996-05-20	1996-05-20	Composizioni farmaceutiche contenenti ciclosporina ed un veicolante comprendente almeno un estere dell'acido alfa-glicerofosforico
PCT/EP1997/002553 WO1997044053A1 (en)	1996-05-20	1997-05-20	Pharmaceutical compositions containing cyclosporine and a carrier comprising at least an ester of alpha-glycerophosphoric acid

Publications (1)

Publication Number	Publication Date
ATE216254T1 true ATE216254T1 (de)	2002-05-15

Family

ID=11374287

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT97924958T ATE216254T1 (de)	1996-05-20	1997-05-20	Pharmazeutische zusammensetzungen enthaltend cyclosporin und einen träger mit mindestens einer ester-alpha-glycerophosphorsäure

Country Status (12)

Country	Link
US (1)	US6194401B1 (de)
EP (1)	EP0901378B1 (de)
JP (1)	JP2000510857A (de)
AT (1)	ATE216254T1 (de)
AU (1)	AU709068B2 (de)
CA (1)	CA2255640A1 (de)
DE (1)	DE69712055D1 (de)
IL (1)	IL127154A0 (de)
IT (1)	IT1282733B1 (de)
NZ (1)	NZ332904A (de)
WO (1)	WO1997044053A1 (de)
ZA (1)	ZA974356B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5858401A (en)	1996-01-22	1999-01-12	Sidmak Laboratories, Inc.	Pharmaceutical composition for cyclosporines
ATE404172T1 (de)	1998-12-30	2008-08-15	Dexcel Ltd	Dispergierbares konzentrat zur verabreichung von cyclosporin
DE10024451A1 (de) *	2000-05-18	2001-11-29	Asta Medica Ag	Pharmazeutische Darreichungsform für Peptide, Verfahren zu deren Herstellung und Verwendung
DE10038699A1 (de) *	2000-07-31	2002-02-14	Michael Sittinger	Mittel zur Verringrung der Abstoßungsreaktionen bei Transplantaten
AR045142A1 (es) *	2003-07-30	2005-10-19	Novartis Ag	Composicion veterinaria masticable ductil de buen sabor
KR100966627B1 (ko) *	2006-06-14	2010-06-29	주식회사 대웅제약	Ｌ-α-글리세로포스포릴 콜린의 제조방법
CA2723540C (en) *	2008-05-08	2016-01-05	United Therapeutics Corporation	Treprostinil monohydrate
WO2010141068A1 (en) *	2009-06-02	2010-12-09	Wu Nian	Opthalmic compositions of cyclosporin

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2515035A1 (fr)	1981-10-26	1983-04-29	Rhone Poulenc Sante	Nouvelle forme galenique solide pour administration par voie orale et son procede de fabrication
JPS5916818A (ja)	1982-07-20	1984-01-28	Shimizu Seiyaku Kk	経静脈投与用輸液剤
US5342625A (en) *	1988-09-16	1994-08-30	Sandoz Ltd.	Pharmaceutical compositions comprising cyclosporins
IT1265647B1 (it)	1992-11-18	1996-11-22	Farmin Srl	Composizione farmaceutiche topiche per le allergie respiratorie
DE4338086A1 (de) *	1993-11-08	1995-05-11	Dietl Hans	Cyclosporin(e) enthaltende pharmazeutische Zubereitung zur oralen Applikation sowie Verfahren zu ihrer Herstellung
EP0697214A1 (de) *	1994-07-19	1996-02-21	Vestar, Inc.	Pharmazeutische Formulierungen mit liposomalem Cyclosporin

1996
- 1996-05-20 IT IT96MI001010A patent/IT1282733B1/it active IP Right Grant
1997
- 1997-05-20 JP JP09541525A patent/JP2000510857A/ja active Pending
- 1997-05-20 DE DE69712055T patent/DE69712055D1/de not_active Expired - Lifetime
- 1997-05-20 IL IL12715497A patent/IL127154A0/xx unknown
- 1997-05-20 AU AU30276/97A patent/AU709068B2/en not_active Ceased
- 1997-05-20 AT AT97924958T patent/ATE216254T1/de not_active IP Right Cessation
- 1997-05-20 US US09/194,002 patent/US6194401B1/en not_active Expired - Fee Related
- 1997-05-20 EP EP97924958A patent/EP0901378B1/de not_active Expired - Lifetime
- 1997-05-20 CA CA002255640A patent/CA2255640A1/en not_active Abandoned
- 1997-05-20 ZA ZA9704356A patent/ZA974356B/xx unknown
- 1997-05-20 NZ NZ332904A patent/NZ332904A/en unknown
- 1997-05-20 WO PCT/EP1997/002553 patent/WO1997044053A1/en not_active Ceased

Also Published As

Publication number	Publication date
IL127154A0 (en)	1999-09-22
JP2000510857A (ja)	2000-08-22
US6194401B1 (en)	2001-02-27
AU709068B2 (en)	1999-08-19
WO1997044053A1 (en)	1997-11-27
IT1282733B1 (it)	1998-03-31
AU3027697A (en)	1997-12-09
ITMI961010A1 (it)	1997-11-20
DE69712055D1 (de)	2002-05-23
CA2255640A1 (en)	1997-11-27
ITMI961010A0 (de)	1996-05-20
EP0901378A1 (de)	1999-03-17
ZA974356B (en)	1998-01-14
NZ332904A (en)	2000-06-23
EP0901378B1 (de)	2002-04-17

Legal Events

Date	Code	Title	Description
2002-10-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
EP0695171A1 (de)	1996-02-07	Gonadotropin enthaltende gefriergetrocknete troepfen
ATA192293A (de)	2000-10-15	Cyclosporin enthaltende pharmazeutische zusammensetzungen
ATE218581T1 (de)	2002-06-15	Cyclosporinderivat, dessen herstellung und pharmazeutische zusammensetzung
DE69713148D1 (de)	2002-07-11	Cyclosporinderivate, deren herstellung und pharmazeutische zusammensetzungen
TR199900239T2 (de)	1999-03-22
TNSN98075A1 (fr)	2005-03-15	Analogues peptidiques de la lh-rh, leur utilisation et les compositions pharmaceutiques les contenant.
BR9707333A (pt)	1999-07-20	Dihidrobenzofurano e compostos relacionados úteis como agentes antinflamatórios
PY950041A (es)	2006-07-03	Compuesto de 1- fenil 3-dimetilamino- propano a procedimientos para su preparacion y a la aplicacion de estas sustancias en farmacologia
DE69414723D1 (de)	1998-12-24	Lyophilisierte stammzellenfaktor formulierungen
BG103664A (en)	2000-03-31	Pharmaceutical forms containing ammoxycillin and clavulanate
EE200000595A (et)	2002-04-15	Toimeaine viimine kandjamaatriksisse
ES2167751T3 (es)	2002-05-16	Preparaciones de insulina conteniendo un halogenuro.
ATE216254T1 (de)	2002-05-15	Pharmazeutische zusammensetzungen enthaltend cyclosporin und einen träger mit mindestens einer ester-alpha-glycerophosphorsäure
ES2133295T3 (es)	1999-09-16	Peptidos ciclicos y su uso.
DE60043442D1 (de)	2010-01-14	Ner aktiven phase und einer inaktiven phase
BR9611472A (pt)	1999-02-02	Compostos de di-terc-butilfenol contendo enxofre úteis como agentes antiinflamatórios
ATE259244T1 (de)	2004-02-15	Vermeidung von gastrointestinaler schädigung
SE9403137D0 (sv)	1994-09-20	Derivatives of carbohydrates and compositions containing them
BR9707342A (pt)	1999-07-20	Dihidrobensofurano e compostos correlatod úteis como agentes antiinflamatórios
ES2162986T3 (es)	2002-01-16	Derivados de mercapto-alcanoil-dipeptidos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
DE69804674D1 (de)	2002-05-08	Liposomen mit mehrfach verzweigten peptidkonstruktionen zur verwendung gegen hiv
IT1302289B1 (it)	2000-09-05	Composizioni farmaceutiche ad attivita' antineoplastica
ES2144501T3 (es)	2000-06-16	Compuestos de quinolina como antagonistas de leucotrienos.
ES2091571T3 (es)	1996-11-01	Nuevos derivados peptidicos activos en los procesos de adhesion celular, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
PT932408E (pt)	2002-04-29	FORMULACOES FARMACEUTICAS E COSMéTICAS COM ACTIVIDADES ANTIMICROBIANA